Boston Scientific Corporation (BSX)

Market Cap	138.71B -2.9%
Revenue (ttm)	19.35B +21.6%
Net Income	2.79B +55.7%
EPS	1.87 +54.7%
Shares Out	1.48B
PE Ratio	50.02
Forward PE	28.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,302,877
Open	93.05
Previous Close	92.33
Day's Range	92.02 - 94.25
52-Week Range	85.98 - 109.50
Beta	0.67
Analysts	Strong Buy
Price Target	124.44 (+33.05%)
Earnings Date	Feb 4, 2026

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 18, 1992
• Employees: 53,000
• Stock Exchange: NYSE
• Ticker Symbol: BSX
• Website: https://www.bostonscientific.com

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Analyst Summary

According to 18 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price target is $124.44, which is an increase of 33.05% from the latest price.

Price Target

$124.44

(33.05% upside)

Analyst Consensus: Strong Buy